期刊文献+

非小细胞肺癌肿瘤血管生成及其影响因素的研究 被引量:4

Angiogenesis and its influrencing factors in non-small cell lung cancer
暂未订购
导出
摘要 目的 :研究非小细胞肺癌 (NSCLC)肿瘤血管生成状态及其影响因素。 方法 :采用免疫组化方法研究 95例NSCLC肿瘤内微血管密度 (IMVD)及其与生物学行为的关系 ,同时分析基质金属蛋白酶 (MMP 2 ,MMP 9)、组织金属蛋白酶抑制物 (TIMP 2 )、血管内皮生长因子 (VEGF)、碱性成纤维细胞生长因子 (b FGF)、CD4 4变异体 6(CD4 4v6 )、一氧化氮合酶 2 (诱生型 ,NOS2 )、一氧化氮合酶 3(内皮型 ,NOS3)以及上皮型钙粘素 (E cad)表达状况对IMVD的影响。 结果 :NSCLC存在着活跃的新血管生成 ,IMVD与NSCLC的临床分期及淋巴结转移密切相关 ;在VEGF、b FGF、CD4 4v6、MMP 2、NOS2及NOS3阳性表达的癌组织中IMVD值显著高于阴性表达的癌组织 ,而TIMP 2、E cad阳性表达的癌组织中IMVD值显著低于阴性表达的癌组织。 结论 :IMVD的检测对于判断NSCLC的预后和淋巴结转移状态具有重要的临床应用价值 ;多种因素参与了NSCLC肿瘤血管生成的调节 ,其中VEGF、b FGF、CD4 4v6、MMP 2、NOS2及NOS3对血管生成起促进作用 ,而TIMP 2和E cad则可能起阻抑作用。 Objective: To study angiogenesis and its influencing factors in human non-small cell lung cancer(NSCLC). Methods: The values of intratumor microvessel density(IMVD) in 95 cases of NSCLC were determined and its correlation with pathological parameters was analyzed. The relationship between IMVD and expressions of MMP-2,MMP-9,TIMP-2,VEGF,b-FGF,CD44v6,NOS2,NOS3 and E-cad in NSCLC was assessed. Results: There was active tumor angiogenesis of NSCLC, and the values of IMVD were correlated with clinicopathological stages of NSCLC and lymph nodes metastasis. The values of IMVD in positive expressions of VEGF, b-FGF, MMP-2, TIMP-2,CD44v6,NOS2 and NOS3 were significantly higher than that in negative expressions, opposed to the expression of TIMP-2 and E-cad. Conclusion:IMVD is a valuable marker for evaluating stages and metastasis of NSCLC. MMP-2, TIMP-2, VEGF, b-FGF, CD44v6, NOS2, NOS3 and E-cad may take part in the regulation of angiogenesis in NSCLC.
出处 《医学研究生学报》 CAS 2004年第1期60-61,64,共3页 Journal of Medical Postgraduates
关键词 非小细胞肺癌 血管生成 微血管密度 影响因素 生物学行为 Non-small cell lung cancer Angiogenesis Intratumor microvessel density
  • 相关文献

参考文献9

二级参考文献13

  • 1Chamber AF,Matrisian LM.Changing views of matrix metalloproteinase in metastasis[J].J Natl Cancer Inst,1997,89:1260-1265.
  • 2Weiderner N. Intratumor nicrovessel density as a prognostic factor in cancer [J].Am J Pathal,1995;147:9-19
  • 3Walkui S,Furusato M, Itoh T, et al. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study[J]. J Pathol, 1992,168:257-262.
  • 4Weiderner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow [J].J pathol,1998,184:119-122.
  • 5Person SL,Watson SA,Brown PD,et al. Matrix metalloproteinases[J]. Br J Surg,1997,84:160-166.
  • 6Person SL,Watson SA,Collins HM,et al.Gelatinase(MMP-2 and MMP-9) ecpressio in gastrointestinal malignancy[J].Br J Comcer,1998,78(11):1495-1502.
  • 7Lamper K,Machein U,Machein MR,et al. Expression of matrix metalloproteinasesand their tissue inhibitors in human brain tumors[J].Am Jpathol,1998,153:429-432.
  • 8Zeng ZS, CohenAM,GuillemJG. Loss of basement membrane type Ⅳ collagen is associated with increased expression of metalloprotemases 2 and 9(MMP-2 and MMP-9) during human colorectal tumorigenesis [J].Carcingenesis, 1999,20(5):749-745.
  • 9陈志营,王虹蛟,金莹.肺癌与一氧化氮合酶表达关系的研究[J].实用肿瘤学杂志,2000,14(2):95-97. 被引量:4
  • 10秦艳芳,向军俭,杨红宇.碱性成纤维细胞生长因子与肿瘤[J].国外医学(肿瘤学分册),2001,28(4):256-259. 被引量:28

共引文献43

同被引文献28

  • 1管晓翔,陈龙邦.非小细胞肺癌循环核酸的研究进展[J].癌症进展,2003,1(4):187-190. 被引量:13
  • 2张阿丽,王全胜,钟亚华,陈刚,李辅军,奚玲,谢丛华,周云峰,马丁.上皮性肿瘤细胞中Snail与E-cadherin的表达及其与体外侵袭性的关系[J].中华肿瘤杂志,2006,28(1):17-20. 被引量:9
  • 3Morinaga S, Nakamura Y, lshiwa N, et al. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma [ J]. Oncol Rep,2004,12(6) :1189-1194.
  • 4Lee JP, Chang KH, Han JH, et al. Survivin, a novel anti-apoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factors[ J]. Int J Gynecol Cancer, 2005,15 ( 1 ) :113-119.
  • 5Fu M, Wang C, Li Z, et al. Minireview : Cyclin D1 : normal and abnormal functions[ J]. Endocrinology, 2004, 145 ( 12 ) :5439-5447.
  • 6Wang C, Li Z, Fu M, et al. Signal transduction mediated by cyclin D1 : from mitogens to cell proliferation: a molecular target with therapeutic potential [ J ]. Cancer Treat Res, 2004,119 ( 6 ) : 217-237.
  • 7Murakami R, Yoshimatsu S, Yamashita Y,et al. Treatment of Hepatocellular carcinoma: value of percutaneous microwave coagulation[J]. Am J Rediol, 1995, 164(5) :1159-1164.
  • 8Dong BW, Liang P, Yu XL, et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients [ J ]. Am J Roentgenol, 2003, 180(60) : 1547-1555.
  • 9Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma[J]. Cancer , 1994, 74(18) :817-825.
  • 10Johnson ME, Howerth EW. Survivin: a bifunctional inhibitor of apoptosis protein[J]. Vet Pathol, 2004,41 (6) :599-607.

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部